Sequential analysis of SB trans vector-mediated gene expression in human T cells as related to DNA amounts used for nucleofection
pT2/DsRed +/- pUbSB10 . | . | . | . | |||
|---|---|---|---|---|---|---|
| Dose, by day . | Geometric mean (n = 8) . | 95% Cl . | P(vs 0 μg) . | |||
| Day 21 | ||||||
| 20 μg | 7.07 | 3.80, 13.16 | < .001 | |||
| 10 μg | 11.04 | 5.93, 20.56 | < .001 | |||
| 5 μg | 7.03 | 3.78, 13.09 | < .001 | |||
| 2.5 μg | 3.63 | 1.95, 6.76 | < .001 | |||
| 0 μg | 0.07 | 0.04, 0.13 | ||||
| Day 28 | ||||||
| 20 μg | 6.64 | 3.99, 11.03 | < .001 | |||
| 10 μg | 10.78 | 6.49, 17.92 | < .001 | |||
| 5 μg | 7.00 | 4.21, 11.63 | < .001 | |||
| 2.5 μg | 3.80 | 2.29, 6.32 | < .001 | |||
| 0 μg | 0.12 | 0.07, 0.20 | ||||
pT2/DsRed +/- pUbSB10 . | . | . | . | |||
|---|---|---|---|---|---|---|
| Dose, by day . | Geometric mean (n = 8) . | 95% Cl . | P(vs 0 μg) . | |||
| Day 21 | ||||||
| 20 μg | 7.07 | 3.80, 13.16 | < .001 | |||
| 10 μg | 11.04 | 5.93, 20.56 | < .001 | |||
| 5 μg | 7.03 | 3.78, 13.09 | < .001 | |||
| 2.5 μg | 3.63 | 1.95, 6.76 | < .001 | |||
| 0 μg | 0.07 | 0.04, 0.13 | ||||
| Day 28 | ||||||
| 20 μg | 6.64 | 3.99, 11.03 | < .001 | |||
| 10 μg | 10.78 | 6.49, 17.92 | < .001 | |||
| 5 μg | 7.00 | 4.21, 11.63 | < .001 | |||
| 2.5 μg | 3.80 | 2.29, 6.32 | < .001 | |||
| 0 μg | 0.12 | 0.07, 0.20 | ||||